Works matching IS 13866346 AND DT 2022 AND VI 52 AND IP 9
Results: 9
Toward the accumulation of evidence for a novel high‐sensitivity hepatitis B core‐related antigen assay in patients with hepatitis B virus infection.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 743, doi. 10.1111/hepr.13815
- Publication type:
- Article
Downregulation of thrombomodulin contributes to ischemia‐reperfusion injury in mice with steatotic liver.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 762, doi. 10.1111/hepr.13802
- By:
- Publication type:
- Article
Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A comparative retrospective study.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 794, doi. 10.1111/hepr.13801
- By:
- Publication type:
- Article
Impact of bodyweight‐based starting doses on the safety and efficacy of lenvatinib in primarily Japanese patients with hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 784, doi. 10.1111/hepr.13800
- By:
- Publication type:
- Article
Analysis of non‐severe acute onset autoimmune hepatitis according to the presence of radiological heterogeneity.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 804, doi. 10.1111/hepr.13799
- By:
- Publication type:
- Article
Clinical implication of immune checkpoint inhibitor on the chronic hepatitis B virus infection.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 754, doi. 10.1111/hepr.13798
- By:
- Publication type:
- Article
Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 773, doi. 10.1111/hepr.13797
- By:
- Publication type:
- Article
Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core‐related antigen assay.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 745, doi. 10.1111/hepr.13761
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 741, doi. 10.1111/hepr.13660
- Publication type:
- Article